Barclays lowered the firm’s price target on Allstate (ALL) to $172 from $183 and keeps an Underweight rating on the shares as part of a Q1 earnings preview for the insurance group. With life earnings facing challenges Barclays favors group benefits, excess capital, and “cheap” cash flows, the analyst tells investors in a research note. The firm says the sector is “navigating uncertainty.”
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ALL:
- Allstate price target lowered to $225 from $229 at Morgan Stanley
- Allstate price target lowered to $228 from $240 at Keefe Bruyette
- Allstate price target raised to $222 from $217 at JPMorgan
- Allstate completes sale of Employer Voluntary Benefits business
- The Standard completes acquisition of Allstate EVB business